| | | | | |
| Click on ATC codes below to search for corresponding drugs in e-Drug3D (some actives substances are not FDA-approved drugs and thus are not present in this database)
More at the ATC website
|
| | | | | |
|
| | | | | |
| Main Group | Therapeutic Group | Pharmacological subgroup | Chemical subgroup | Active substance |
| | | | | |
| A ALIMENTARY TRACT AND METABOLISM |
| | | | | |
| A01 STOMATOLOGICAL PREPARATIONS | | | |
| | A01A STOMATOLOGICAL PREPARATIONS | | |
| | | A01AA Caries prophylactic agents | |
| | | A01AB Antiinfectives and antiseptics for local oral treatment | |
| | | A01AC Corticosteroids for local oral treatment | |
| | | A01AD Other agents for local oral treatment | |
| A02 DRUGS FOR ACID RELATED DISORDERS | | | |
| | A02A ANTACIDS | | |
| | | A02AA Magnesium compounds | |
| | | A02AB Aluminium compounds | |
| | | A02AC Calcium compounds | |
| | | A02AD Combinations and complexes of aluminium, calcium and magnesium compounds | |
| | | A02AF Antacids with antiflatulents | |
| | | A02AG Antacids with antispasmodics | |
| | | A02AH Antacids with sodium bicarbonate | |
| | | A02AX Antacids, other combinations | |
| | A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | | |
| | | A02BA H2-receptor antagonists | |
| | | A02BB Prostaglandins | |
| | | A02BC Proton pump inhibitors | |
| | | A02BD Combinations for eradication of Helicobacter pylori | |
| | | A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | |
| | A02X OTHER DRUGS FOR ACID RELATED DISORDERS | | |
| A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | | | |
| | A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | | |
| | | A03AA Synthetic anticholinergics, esters with tertiary amino group | |
| | | A03AB Synthetic anticholinergics, quaternary ammonium compounds | |
| | | A03AC Synthetic antispasmodics, amides with tertiary amines | |
| | | A03AD Papaverine and derivatives | |
| | | A03AE Serotonin receptor antagonists | |
| | | A03AX Other drugs for functional gastrointestinal disorders | |
| | A03B BELLADONNA AND DERIVATIVES, PLAIN | | |
| | | A03BA Belladonna alkaloids, tertiary amines | |
| | | A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | |
| | A03C ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | | |
| | | A03CA Synthetic anticholinergic agents in combination with psycholeptics | |
| | | A03CB Belladonna and derivatives in combination with psycholeptics | |
| | | A03CC Other antispasmodics in combination with psycholeptics | |
| | A03D ANTISPASMODICS IN COMBINATION WITH ANALGESICS | | |
| | | A03DA Synthetic anticholinergic agents in combination with analgesics | |
| | | A03DB Belladonna and derivatives in combination with analgesics | |
| | | A03DC Other antispasmodics in combination with analgesics | |
| | A03E ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS | | |
| | | A03EA Antispasmodics, psycholeptics and analgesics in combination | |
| | | A03ED Antispasmodics in combination with other drugs | |
| | A03F PROPULSIVES | | |
| | | A03FA Propulsives | |
| A04 ANTIEMETICS AND ANTINAUSEANTS | | | |
| | A04A ANTIEMETICS AND ANTINAUSEANTS | | |
| | | A04AA Serotonin (5HT3) antagonists | |
| | | A04AD Other antiemetics | |
| A05 BILE AND LIVER THERAPY | | | |
| | A05A BILE THERAPY | | |
| | | A05AA Bile acids and derivatives | |
| | | A05AB Preparations for biliary tract therapy | |
| | | A05AX Other drugs for bile therapy | |
| | A05B LIVER THERAPY, LIPOTROPICS | | |
| | | A05BA Liver therapy | |
| | A05C DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION | | |
| A06 DRUGS FOR CONSTIPATION | | | |
| | A06A DRUGS FOR CONSTIPATION | | |
| | | A06AA Softeners, emollients | |
| | | A06AB Contact laxatives | |
| | | A06AC Bulk-forming laxatives | |
| | | A06AD Osmotically acting laxatives | |
| | | A06AG Enemas | |
| | | A06AH Peripheral opioid receptor antagonists | |
| | | A06AX Other drugs for constipation | |
| A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | | | |
| | A07A INTESTINAL ANTIINFECTIVES | | |
| | | A07AA Antibiotics | |
| | | A07AB Sulfonamides | |
| | | A07AC Imidazole derivatives | |
| | | A07AX Other intestinal antiinfectives | |
| | A07B INTESTINAL ADSORBENTS | | |
| | | A07BA Charcoal preparations | |
| | | A07BB Bismuth preparations | |
| | | A07BC Other intestinal adsorbents | |
| | A07C ELECTROLYTES WITH CARBOHYDRATES | | |
| | | A07CA Oral rehydration salt formulations | |
| | A07D ANTIPROPULSIVES | | |
| | | A07DA Antipropulsives | |
| | A07E INTESTINAL ANTIINFLAMMATORY AGENTS | | |
| | | A07EA Corticosteroids acting locally | |
| | | A07EB Antiallergic agents, excl. corticosteroids | |
| | | A07EC Aminosalicylic acid and similar agents | |
| | A07F ANTIDIARRHEAL MICROORGANISMS | | |
| | | A07FA Antidiarrheal microorganisms | |
| | A07X OTHER ANTIDIARRHEALS | | |
| | | A07XA Other antidiarrheals | |
| A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | | | |
| | A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | | |
| | | A08AA Centrally acting antiobesity products | |
| | | A08AB Peripherally acting antiobesity products | |
| | | A08AX Other antiobesity drugs | |
| A09 DIGESTIVES, INCL. ENZYMES | | | |
| | A09A DIGESTIVES, INCL. ENZYMES | | |
| | | A09AA Enzyme preparations | |
| | | A09AB Acid preparations | |
| | | A09AC Enzyme and acid preparations, combinations | |
| A10 DRUGS USED IN DIABETES | | | |
| | A10A INSULINS AND ANALOGUES | | |
| | | A10AB Insulins and analogues for injection, fast-acting | |
| | | A10AC Insulins and analogues for injection, intermediate-acting | |
| | | A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting | |
| | | A10AE Insulins and analogues for injection, long-acting | |
| | | A10AF Insulins and analogues for inhalation | |
| | A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | | |
| | | A10BA Biguanides | |
| | | A10BB Sulfonylureas | |
| | | A10BC Sulfonamides (heterocyclic) | |
| | | A10BD Combinations of oral blood glucose lowering drugs | |
| | | A10BF Alpha glucosidase inhibitors | |
| | | A10BG Thiazolidinediones | |
| | | A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors | |
| | | A10BJ Glucagon-like peptide-1 (GLP-1) analogues | |
| | | A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors | |
| | | A10BX Other blood glucose lowering drugs, excl. insulins | |
| | A10X OTHER DRUGS USED IN DIABETES | | |
| | | A10XA Aldose reductase inhibitors | |
| A11 VITAMINS | | | |
| | A11A MULTIVITAMINS, COMBINATIONS | | |
| | | A11AA Multivitamins with minerals | |
| | | A11AB Multivitamins, other combinations | |
| | A11B MULTIVITAMINS, PLAIN | | |
| | | A11BA Multivitamins, plain | |
| | A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO | | |
| | | A11CA Vitamin A, plain | |
| | | A11CB Vitamin A and D in combination | |
| | | A11CC Vitamin D and analogues | |
| | A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 | | |
| | | A11DA Vitamin B1, plain | |
| | | A11DB Vitamin B1 in combination with vitamin B6 and/or vitamin B12 | |
| | A11E VITAMIN B-COMPLEX, INCL. COMBINATIONS | | |
| | | A11EA Vitamin B-complex, plain | |
| | | A11EB Vitamin B-complex with vitamin C | |
| | | A11EC Vitamin B-complex with minerals | |
| | | A11ED Vitamin B-complex with anabolic steroids | |
| | | A11EX Vitamin B-complex, other combinations | |
| | A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS | | |
| | | A11GA Ascorbic acid (vitamin C), plain | |
| | | A11GB Ascorbic acid (vitamin C), combinations | |
| | A11H OTHER PLAIN VITAMIN PREPARATIONS | | |
| | | A11HA Other plain vitamin preparations | |
| | A11J OTHER VITAMIN PRODUCTS, COMBINATIONS | | |
| | | A11JA Combinations of vitamins | |
| | | A11JB Vitamins with minerals | |
| | | A11JC Vitamins, other combinations | |
| A12 MINERAL SUPPLEMENTS | | | |
| | A12A CALCIUM | | |
| | | A12AA Calcium | |
| | | A12AX Calcium, combinations with vitamin D and/or other drugs | |
| | A12B POTASSIUM | | |
| | | A12BA Potassium | |
| | A12C OTHER MINERAL SUPPLEMENTS | | |
| | | A12CA Sodium | |
| | | A12CB Zinc | |
| | | A12CC Magnesium | |
| | | A12CD Fluoride | |
| | | A12CE Selenium | |
| | | A12CX Other mineral products | |
| A13 TONICS | | | |
| | A13A TONICS | | |
| A14 ANABOLIC AGENTS FOR SYSTEMIC USE | | | |
| | A14A ANABOLIC STEROIDS | | |
| | | A14AA Androstan derivatives | |
| | | A14AB Estren derivatives | |
| | A14B OTHER ANABOLIC AGENTS | | |
| A15 APPETITE STIMULANTS | | | |
| A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | | | |
| | A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | | |
| | | A16AA Amino acids and derivatives | |
| | | A16AB Enzymes | |
| | | A16AX Various alimentary tract and metabolism products | |
| | | | | |
| B BLOOD AND BLOOD FORMING ORGANS |
| | | | | |
| B01 ANTITHROMBOTIC AGENTS | | | |
| | B01A ANTITHROMBOTIC AGENTS | | |
| | | B01AA Vitamin K antagonists | |
| | | B01AB Heparin group | |
| | | B01AC Platelet aggregation inhibitors excl. heparin | |
| | | B01AD Enzymes | |
| | | B01AE Direct thrombin inhibitors | |
| | | B01AF Direct factor Xa inhibitors | |
| | | B01AX Other antithrombotic agents | |
| B02 ANTIHEMORRHAGICS | | | |
| | B02A ANTIFIBRINOLYTICS | | |
| | | B02AA Amino acids | |
| | | B02AB Proteinase inhibitors | |
| | B02B VITAMIN K AND OTHER HEMOSTATICS | | |
| | | B02BA Vitamin K | |
| | | B02BB Fibrinogen | |
| | | B02BC Local hemostatics | |
| | | B02BD Blood coagulation factors | |
| | | B02BX Other systemic hemostatics | |
| B03 ANTIANEMIC PREPARATIONS | | | |
| | B03A IRON PREPARATIONS | | |
| | | B03AA Iron bivalent, oral preparations | |
| | | B03AB Iron trivalent, oral preparations | |
| | | B03AC Iron, parenteral preparations | |
| | | B03AD Iron in combination with folic acid | |
| | | B03AE Iron in other combinations | |
| | B03B VITAMIN B12 AND FOLIC ACID | | |
| | | B03BA Vitamin B12 (cyanocobalamin and analogues) | |
| | | B03BB Folic acid and derivatives | |
| | B03X OTHER ANTIANEMIC PREPARATIONS | | |
| | | B03XA Other antianemic preparations | |
| B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS | | | |
| | B05A BLOOD AND RELATED PRODUCTS | | |
| | | B05AA Blood substitutes and plasma protein fractions | |
| | | B05AX Other blood products | |
| | B05B I.V. SOLUTIONS | | |
| | | B05BA Solutions for parenteral nutrition | |
| | | B05BB Solutions affecting the electrolyte balance | |
| | | B05BC Solutions producing osmotic diuresis | |
| | B05C IRRIGATING SOLUTIONS | | |
| | | B05CA Antiinfectives | |
| | | B05CB Salt solutions | |
| | | B05CX Other irrigating solutions | |
| | B05D PERITONEAL DIALYTICS | | |
| | | B05DA Isotonic solutions | |
| | | B05DB Hypertonic solutions | |
| | B05X I.V. SOLUTION ADDITIVES | | |
| | | B05XA Electrolyte solutions | |
| | | B05XB Amino acids | |
| | | B05XC Vitamins | |
| | | B05XX Other i.v. solution additives | |
| | B05Z HEMODIALYTICS AND HEMOFILTRATES | | |
| | | B05ZA Hemodialytics, concentrates | |
| | | B05ZB Hemofiltrates | |
| B06 OTHER HEMATOLOGICAL AGENTS | | | |
| | B06A OTHER HEMATOLOGICAL AGENTS | | |
| | | B06AA Enzymes | |
| | | B06AB Heme products | |
| | | B06AC Drugs used in hereditary angioedema | |
| | | B06AX Other hematological agents | |
| | | | | |
| C CARDIOVASCULAR SYSTEM |
| | | | | |
| C01 CARDIAC THERAPY | | | |
| | C01A CARDIAC GLYCOSIDES | | |
| | | C01AA Digitalis glycosides | |
| | | C01AB Scilla glycosides | |
| | | C01AC Strophanthus glycosides | |
| | | C01AX Other cardiac glycosides | |
| | C01B ANTIARRHYTHMICS, CLASS I AND III | | |
| | | C01BA Antiarrhythmics, class Ia | |
| | | C01BB Antiarrhythmics, class Ib | |
| | | C01BC Antiarrhythmics, class Ic | |
| | | C01BD Antiarrhythmics, class III | |
| | | C01BG Other antiarrhythmics, class I and III | |
| | C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES | | |
| | | C01CA Adrenergic and dopaminergic agents | |
| | | C01CE Phosphodiesterase inhibitors | |
| | | C01CX Other cardiac stimulants | |
| | C01D VASODILATORS USED IN CARDIAC DISEASES | | |
| | | C01DA Organic nitrates | |
| | | C01DB Quinolone vasodilators | |
| | | C01DX Other vasodilators used in cardiac diseases | |
| | C01E OTHER CARDIAC PREPARATIONS | | |
| | | C01EA Prostaglandins | |
| | | C01EB Other cardiac preparations | |
| | | C01EX Other cardiac combination products | |
| C02 ANTIHYPERTENSIVES | | | |
| | C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING | | |
| | | C02AA Rauwolfia alkaloids | |
| | | C02AB Methyldopa | |
| | | C02AC Imidazoline receptor agonists | |
| | C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING | | |
| | | C02BA Sulfonium derivatives | |
| | | C02BB Secondary and tertiary amines | |
| | | C02BC Bisquaternary ammonium compounds | |
| | C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING | | |
| | | C02CA Alpha-adrenoreceptor antagonists | |
| | | C02CC Guanidine derivatives | |
| | C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON | | |
| | | C02DA Thiazide derivatives | |
| | | C02DB Hydrazinophthalazine derivatives | |
| | | C02DC Pyrimidine derivatives | |
| | | C02DD Nitroferricyanide derivatives | |
| | | C02DG Guanidine derivatives | |
| | C02K OTHER ANTIHYPERTENSIVES | | |
| | | C02KA Alkaloids, excl. rauwolfia | |
| | | C02KB Tyrosine hydroxylase inhibitors | |
| | | C02KC MAO inhibitors | |
| | | C02KD Serotonin antagonists | |
| | | C02KX Antihypertensives for pulmonary arterial hypertension | |
| | C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION | | |
| | | C02LA Rauwolfia alkaloids and diuretics in combination | |
| | | C02LB Methyldopa and diuretics in combination | |
| | | C02LC Imidazoline receptor agonists in combination with diuretics | |
| | | C02LE Alpha-adrenoreceptor antagonists and diuretics | |
| | | C02LF Guanidine derivatives and diuretics | |
| | | C02LG Hydrazinophthalazine derivatives and diuretics | |
| | | C02LK Alkaloids, excl. rauwolfia, in combination with diuretics | |
| | | C02LL MAO inhibitors and diuretics | |
| | | C02LN Serotonin antagonists and diuretics | |
| | | C02LX Other antihypertensives and diuretics | |
| | C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 | | |
| C03 DIURETICS | | | |
| | C03A LOW-CEILING DIURETICS, THIAZIDES | | |
| | | C03AA Thiazides, plain | |
| | | C03AB Thiazides and potassium in combination | |
| | | C03AH Thiazides, combinations with psycholeptics and/or analgesics | |
| | | C03AX Thiazides, combinations with other drugs | |
| | C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES | | |
| | | C03BA Sulfonamides, plain | |
| | | C03BB Sulfonamides and potassium in combination | |
| | | C03BC Mercurial diuretics | |
| | | C03BD Xanthine derivatives | |
| | | C03BK Sulfonamides, combinations with other drugs | |
| | | C03BX Other low-ceiling diuretics | |
| | C03C HIGH-CEILING DIURETICS | | |
| | | C03CA Sulfonamides, plain | |
| | | C03CB Sulfonamides and potassium in combination | |
| | | C03CC Aryloxyacetic acid derivatives | |
| | | C03CD Pyrazolone derivatives | |
| | | C03CX Other high-ceiling diuretics | |
| | C03D ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS | | |
| | | C03DA Aldosterone antagonists | |
| | | C03DB Other potassium-sparing agents | |
| | C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION | | |
| | | C03EA Low-ceiling diuretics and potassium-sparing agents | |
| | | C03EB High-ceiling diuretics and potassium-sparing agents | |
| | C03X OTHER DIURETICS | | |
| | | C03XA Vasopressin antagonists | |
| C04 PERIPHERAL VASODILATORS | | | |
| | C04A PERIPHERAL VASODILATORS | | |
| | | C04AA 2-amino-1-phenylethanol derivatives | |
| | | C04AB Imidazoline derivatives | |
| | | C04AC Nicotinic acid and derivatives | |
| | | C04AD Purine derivatives | |
| | | C04AE Ergot alkaloids | |
| | | C04AF Enzymes | |
| | | C04AX Other peripheral vasodilators | |
| C05 VASOPROTECTIVES | | | |
| | C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | | |
| | | C05AA Corticosteroids | |
| | | C05AB Antibiotics | |
| | | C05AD Local anesthetics | |
| | | C05AE Muscle relaxants | |
| | | C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use | |
| | C05B ANTIVARICOSE THERAPY | | |
| | | C05BA Heparins or heparinoids for topical use | |
| | | C05BB Sclerosing agents for local injection | |
| | | C05BX Other sclerosing agents | |
| | C05C CAPILLARY STABILIZING AGENTS | | |
| | | C05CA Bioflavonoids | |
| | | C05CX Other capillary stabilizing agents | |
| C07 BETA BLOCKING AGENTS | | | |
| | C07A BETA BLOCKING AGENTS | | |
| | | C07AA Beta blocking agents, non-selective | |
| | | C07AB Beta blocking agents, selective | |
| | | C07AG Alpha and beta blocking agents | |
| | C07B BETA BLOCKING AGENTS AND THIAZIDES | | |
| | | C07BA Beta blocking agents, non-selective, and thiazides | |
| | | C07BB Beta blocking agents, selective, and thiazides | |
| | | C07BG Alpha and beta blocking agents and thiazides | |
| | C07C BETA BLOCKING AGENTS AND OTHER DIURETICS | | |
| | | C07CA Beta blocking agents, non-selective, and other diuretics | |
| | | C07CB Beta blocking agents, selective, and other diuretics | |
| | | C07CG Alpha and beta blocking agents and other diuretics | |
| | C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS | | |
| | | C07DA Beta blocking agents, non-selective, thiazides and other diuretics | |
| | | C07DB Beta blocking agents, selective, thiazides and other diuretics | |
| | C07E BETA BLOCKING AGENTS AND VASODILATORS | | |
| | | C07EA Beta blocking agents, non-selective, and vasodilators | |
| | | C07EB Beta blocking agents, selective, and vasodilators | |
| | C07F BETA BLOCKING AGENTS, OTHER COMBINATIONS | | |
| | | C07FB Beta blocking agents and calcium channel blockers | |
| | | C07FX Beta blocking agents, other combinations | |
| C08 CALCIUM CHANNEL BLOCKERS | | | |
| | C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS | | |
| | | C08CA Dihydropyridine derivatives | |
| | | C08CX Other selective calcium channel blockers with mainly vascular effects | |
| | C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | | |
| | | C08DA Phenylalkylamine derivatives | |
| | | C08DB Benzothiazepine derivatives | |
| | C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS | | |
| | | C08EA Phenylalkylamine derivatives | |
| | | C08EX Other non-selective calcium channel blockers | |
| | C08G CALCIUM CHANNEL BLOCKERS AND DIURETICS | | |
| | | C08GA Calcium channel blockers and diuretics | |
| C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | | | |
| | C09A ACE INHIBITORS, PLAIN | | |
| | | C09AA ACE inhibitors, plain | |
| | C09B ACE INHIBITORS, COMBINATIONS | | |
| | | C09BA ACE inhibitors and diuretics | |
| | | C09BB ACE inhibitors and calcium channel blockers | |
| | | C09BX ACE inhibitors, other combinations | |
| | C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN | | |
| | | C09CA Angiotensin II receptor blockers (ARBs), plain | |
| | C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS | | |
| | | C09DA Angiotensin II receptor blockers (ARBs) and diuretics | |
| | | C09DB Angiotensin II receptor blockers (ARBs) and calcium channel blockers | |
| | | C09DX Angiotensin II receptor blockers (ARBs), other combinations | |
| | C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | | |
| | | C09XA Renin-inhibitors | |
| C10 LIPID MODIFYING AGENTS | | | |
| | C10A LIPID MODIFYING AGENTS, PLAIN | | |
| | | C10AA HMG CoA reductase inhibitors | |
| | | C10AB Fibrates | |
| | | C10AC Bile acid sequestrants | |
| | | C10AD Nicotinic acid and derivatives | |
| | | C10AX Other lipid modifying agents | |
| | C10B LIPID MODIFYING AGENTS, COMBINATIONS | | |
| | | C10BA Combinations of various lipid modifying agents | |
| | | C10BX Lipid modifying agents in combination with other drugs | |
| | | | | |
| D DERMATOLOGICALS |
| | | | | |
| D01 ANTIFUNGALS FOR DERMATOLOGICAL USE | | | |
| | D01A ANTIFUNGALS FOR TOPICAL USE | | |
| | | D01AA Antibiotics | |
| | | D01AC Imidazole and triazole derivatives | |
| | | D01AE Other antifungals for topical use | |
| | D01B ANTIFUNGALS FOR SYSTEMIC USE | | |
| | | D01BA Antifungals for systemic use | |
| D02 EMOLLIENTS AND PROTECTIVES | | | |
| | D02A EMOLLIENTS AND PROTECTIVES | | |
| | | D02AA Silicone products | |
| | | D02AB Zinc products | |
| | | D02AC Soft paraffin and fat products | |
| | | D02AD Liquid plasters | |
| | | D02AE Carbamide products | |
| | | D02AF Salicylic acid preparations | |
| | | D02AX Other emollients and protectives | |
| | D02B PROTECTIVES AGAINST UV-RADIATION | | |
| | | D02BA Protectives against UV-radiation for topical use | |
| | | D02BB Protectives against UV-radiation for systemic use | |
| D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS | | | |
| | D03A CICATRIZANTS | | |
| | | D03AA Cod-liver oil ointments | |
| | | D03AX Other cicatrizants | |
| | D03B ENZYMES | | |
| | | D03BA Proteolytic enzymes | |
| D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. | | | |
| | D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. | | |
| | | D04AA Antihistamines for topical use | |
| | | D04AB Anesthetics for topical use | |
| | | D04AX Other antipruritics | |
| D05 ANTIPSORIATICS | | | |
| | D05A ANTIPSORIATICS FOR TOPICAL USE | | |
| | | D05AA Tars | |
| | | D05AC Antracen derivatives | |
| | | D05AD Psoralens for topical use | |
| | | D05AX Other antipsoriatics for topical use | |
| | D05B ANTIPSORIATICS FOR SYSTEMIC USE | | |
| | | D05BA Psoralens for systemic use | |
| | | D05BB Retinoids for treatment of psoriasis | |
| | | D05BX Other antipsoriatics for systemic use | |
| D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE | | | |
| | D06A ANTIBIOTICS FOR TOPICAL USE | | |
| | | D06AA Tetracycline and derivatives | |
| | | D06AX Other antibiotics for topical use | |
| | D06B CHEMOTHERAPEUTICS FOR TOPICAL USE | | |
| | | D06BA Sulfonamides | |
| | | D06BB Antivirals | |
| | | D06BX Other chemotherapeutics | |
| | D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS | | |
| D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | | | |
| | D07A CORTICOSTEROIDS, PLAIN | | |
| | | D07AA Corticosteroids, weak (group I) | |
| | | D07AB Corticosteroids, moderately potent (group II) | |
| | | D07AC Corticosteroids, potent (group III) | |
| | | D07AD Corticosteroids, very potent (group IV) | |
| | D07B CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS | | |
| | | D07BA Corticosteroids, weak, combinations with antiseptics | |
| | | D07BB Corticosteroids, moderately potent, combinations with antiseptics | |
| | | D07BC Corticosteroids, potent, combinations with antiseptics | |
| | | D07BD Corticosteroids, very potent, combinations with antiseptics | |
| | D07C CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS | | |
| | | D07CA Corticosteroids, weak, combinations with antibiotics | |
| | | D07CB Corticosteroids, moderately potent, combinations with antibiotics | |
| | | D07CC Corticosteroids, potent, combinations with antibiotics | |
| | | D07CD Corticosteroids, very potent, combinations with antibiotics | |
| | D07X CORTICOSTEROIDS, OTHER COMBINATIONS | | |
| | | D07XA Corticosteroids, weak, other combinations | |
| | | D07XB Corticosteroids, moderately potent, other combinations | |
| | | D07XC Corticosteroids, potent, other combinations | |
| | | D07XD Corticosteroids, very potent, other combinations | |
| D08 ANTISEPTICS AND DISINFECTANTS | | | |
| | D08A ANTISEPTICS AND DISINFECTANTS | | |
| | | D08AA Acridine derivatives | |
| | | D08AB Aluminium agents | |
| | | D08AC Biguanides and amidines | |
| | | D08AD Boric acid products | |
| | | D08AE Phenol and derivatives | |
| | | D08AF Nitrofuran derivatives | |
| | | D08AG Iodine products | |
| | | D08AH Quinoline derivatives | |
| | | D08AJ Quaternary ammonium compounds | |
| | | D08AK Mercurial products | |
| | | D08AL Silver compounds | |
| | | D08AX Other antiseptics and disinfectants | |
| D09 MEDICATED DRESSINGS | | | |
| | D09A MEDICATED DRESSINGS | | |
| | | D09AA Medicated dressings with antiinfectives | |
| | | D09AB Zinc bandages | |
| | | D09AX Soft paraffin dressings | |
| D10 ANTI-ACNE PREPARATIONS | | | |
| | D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE | | |
| | | D10AA Corticosteroids, combinations for treatment of acne | |
| | | D10AB Preparations containing sulfur | |
| | | D10AD Retinoids for topical use in acne | |
| | | D10AE Peroxides | |
| | | D10AF Antiinfectives for treatment of acne | |
| | | D10AX Other anti-acne preparations for topical use | |
| | D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE | | |
| | | D10BA Retinoids for treatment of acne | |
| | | D10BX Other anti-acne preparations for systemic use | |
| D11 OTHER DERMATOLOGICAL PREPARATIONS | | | |
| | D11A OTHER DERMATOLOGICAL PREPARATIONS | | |
| | | D11AA Antihidrotics | |
| | | D11AC Medicated shampoos | |
| | | D11AE Androgens for topical use | |
| | | D11AF Wart and anti-corn preparations | |
| | | D11AH Agents for dermatitis, excluding corticosteroids | |
| | | D11AX Other dermatologicals | |
| | | | | |
| G GENITO URINARY SYSTEM AND SEX HORMONES |
| | | | | |
| G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | | | |
| | G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | | |
| | | G01AA Antibiotics | |
| | | G01AB Arsenic compounds | |
| | | G01AC Quinoline derivatives | |
| | | G01AD Organic acids | |
| | | G01AE Sulfonamides | |
| | | G01AF Imidazole derivatives | |
| | | G01AG Triazole derivatives | |
| | | G01AX Other antiinfectives and antiseptics | |
| | G01B ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS | | |
| | | G01BA Antibiotics and corticosteroids | |
| | | G01BC Quinoline derivatives and corticosteroids | |
| | | G01BD Antiseptics and corticosteroids | |
| | | G01BE Sulfonamides and corticosteroids | |
| | | G01BF Imidazole derivatives and corticosteroids | |
| G02 OTHER GYNECOLOGICALS | | | |
| | G02A UTEROTONICS | | |
| | | G02AB Ergot alkaloids | |
| | | G02AC Ergot alkaloids and oxytocin incl. analogues, in combination | |
| | | G02AD Prostaglandins | |
| | | G02AX Other uterotonics | |
| | G02B CONTRACEPTIVES FOR TOPICAL USE | | |
| | | G02BA Intrauterine contraceptives | |
| | | G02BB Intravaginal contraceptives | |
| | G02C OTHER GYNECOLOGICALS | | |
| | | G02CA Sympathomimetics, labour repressants | |
| | | G02CB Prolactine inhibitors | |
| | | G02CC Antiinflammatory products for vaginal administration | |
| | | G02CX Other gynecologicals | |
| G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | | | |
| | G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | | |
| | | G03AA Progestogens and estrogens, fixed combinations | |
| | | G03AB Progestogens and estrogens, sequential preparations | |
| | | G03AC Progestogens | |
| | | G03AD Emergency contraceptives | |
| | G03B ANDROGENS | | |
| | | G03BA 3-oxoandrosten (4) derivatives | |
| | | G03BB 5-androstanon (3) derivatives | |
| | G03C ESTROGENS | | |
| | | G03CA Natural and semisynthetic estrogens, plain | |
| | | G03CB Synthetic estrogens, plain | |
| | | G03CC Estrogens, combinations with other drugs | |
| | | G03CX Other estrogens | |
| | G03D PROGESTOGENS | | |
| | | G03DA Pregnen (4) derivatives | |
| | | G03DB Pregnadien derivatives | |
| | | G03DC Estren derivatives | |
| | G03E ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION | | |
| | | G03EA Androgens and estrogens | |
| | | G03EB Androgen, progestogen and estrogen in combination | |
| | | G03EK Androgens and female sex hormones in combination with other drugs | |
| | G03F PROGESTOGENS AND ESTROGENS IN COMBINATION | | |
| | | G03FA Progestogens and estrogens, fixed combinations | |
| | | G03FB Progestogens and estrogens, sequential preparations | |
| | G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS | | |
| | | G03GA Gonadotropins | |
| | | G03GB Ovulation stimulants, synthetic | |
| | G03H ANTIANDROGENS | | |
| | | G03HA Antiandrogens, plain | |
| | | G03HB Antiandrogens and estrogens | |
| | G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | | |
| | | G03XA Antigonadotropins and similar agents | |
| | | G03XB Progesterone receptor modulators | |
| | | G03XC Selective estrogen receptor modulators | |
| | | G03XX Other sex hormones and modulators of the genital system | |
| G04 UROLOGICALS | | | |
| | G04B UROLOGICALS | | |
| | | G04BA Acidifiers | |
| | | G04BC Urinary concrement solvents | |
| | | G04BD Drugs for urinary frequency and incontinence | |
| | | G04BE Drugs used in erectile dysfunction | |
| | | G04BX Other urologicals | |
| | G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY | | |
| | | G04CA Alpha-adrenoreceptor antagonists | |
| | | G04CB Testosterone-5-alpha reductase inhibitors | |
| | | G04CX Other drugs used in benign prostatic hypertrophy | |
| | | | | |
| H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS |
| | | | | |
| H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES | | | |
| | H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES | | |
| | | H01AA ACTH | |
| | | H01AB Thyrotropin | |
| | | H01AC Somatropin and somatropin agonists | |
| | | H01AX Other anterior pituitary lobe hormones and analogues | |
| | H01B POSTERIOR PITUITARY LOBE HORMONES | | |
| | | H01BA Vasopressin and analogues | |
| | | H01BB Oxytocin and analogues | |
| | H01C HYPOTHALAMIC HORMONES | | |
| | | H01CA Gonadotropin-releasing hormones | |
| | | H01CB Somatostatin and analogues | |
| | | H01CC Anti-gonadotropin-releasing hormones | |
| H02 CORTICOSTEROIDS FOR SYSTEMIC USE | | | |
| | H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | | |
| | | H02AA Mineralocorticoids | |
| | | H02AB Glucocorticoids | |
| | H02B CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS | | |
| | | H02BX Corticosteroids for systemic use, combinations | |
| | H02C ANTIADRENAL PREPARATIONS | | |
| | | H02CA Anticorticosteroids | |
| H03 THYROID THERAPY | | | |
| | H03A THYROID PREPARATIONS | | |
| | | H03AA Thyroid hormones | |
| | H03B ANTITHYROID PREPARATIONS | | |
| | | H03BA Thiouracils | |
| | | H03BB Sulfur-containing imidazole derivatives | |
| | | H03BC Perchlorates | |
| | | H03BX Other antithyroid preparations | |
| | H03C IODINE THERAPY | | |
| | | H03CA Iodine therapy | |
| H04 PANCREATIC HORMONES | | | |
| | H04A GLYCOGENOLYTIC HORMONES | | |
| | | H04AA Glycogenolytic hormones | |
| H05 CALCIUM HOMEOSTASIS | | | |
| | H05A PARATHYROID HORMONES AND ANALOGUES | | |
| | | H05AA Parathyroid hormones and analogues | |
| | H05B ANTI-PARATHYROID AGENTS | | |
| | | H05BA Calcitonin preparations | |
| | | H05BX Other anti-parathyroid agents | |
| | | | | |
| J ANTIINFECTIVES FOR SYSTEMIC USE |
| | | | | |
| J01 ANTIBACTERIALS FOR SYSTEMIC USE | | | |
| | J01A TETRACYCLINES | | |
| | | J01AA Tetracyclines | |
| | J01B AMPHENICOLS | | |
| | | J01BA Amphenicols | |
| | J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS | | |
| | | J01CA Penicillins with extended spectrum | |
| | | J01CE Beta-lactamase sensitive penicillins | |
| | | J01CF Beta-lactamase resistant penicillins | |
| | | J01CG Beta-lactamase inhibitors | |
| | | J01CR Combinations of penicillins, incl. beta-lactamase inhibitors | |
| | J01D OTHER BETA-LACTAM ANTIBACTERIALS | | |
| | | J01DB First-generation cephalosporins | |
| | | J01DC Second-generation cephalosporins | |
| | | J01DD Third-generation cephalosporins | |
| | | J01DE Fourth-generation cephalosporins | |
| | | J01DF Monobactams | |
| | | J01DH Carbapenems | |
| | | J01DI Other cephalosporins and penems | |
| | J01E SULFONAMIDES AND TRIMETHOPRIM | | |
| | | J01EA Trimethoprim and derivatives | |
| | | J01EB Short-acting sulfonamides | |
| | | J01EC Intermediate-acting sulfonamides | |
| | | J01ED Long-acting sulfonamides | |
| | | J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives | |
| | J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | | |
| | | J01FA Macrolides | |
| | | J01FF Lincosamides | |
| | | J01FG Streptogramins | |
| | J01G AMINOGLYCOSIDE ANTIBACTERIALS | | |
| | | J01GA Streptomycins | |
| | | J01GB Other aminoglycosides | |
| | J01M QUINOLONE ANTIBACTERIALS | | |
| | | J01MA Fluoroquinolones | |
| | | J01MB Other quinolones | |
| | J01R COMBINATIONS OF ANTIBACTERIALS | | |
| | | J01RA Combinations of antibacterials | |
| | J01X OTHER ANTIBACTERIALS | | |
| | | J01XA Glycopeptide antibacterials | |
| | | J01XB Polymyxins | |
| | | J01XC Steroid antibacterials | |
| | | J01XD Imidazole derivatives | |
| | | J01XE Nitrofuran derivatives | |
| | | J01XX Other antibacterials | |
| J02 ANTIMYCOTICS FOR SYSTEMIC USE | | | |
| | J02A ANTIMYCOTICS FOR SYSTEMIC USE | | |
| | | J02AA Antibiotics | |
| | | J02AB Imidazole derivatives | |
| | | J02AC Triazole and tetrazole derivatives | |
| | | J02AX Other antimycotics for systemic use | |
| J04 ANTIMYCOBACTERIALS | | | |
| | J04A DRUGS FOR TREATMENT OF TUBERCULOSIS | | |
| | | J04AA Aminosalicylic acid and derivatives | |
| | | J04AB Antibiotics | |
| | | J04AC Hydrazides | |
| | | J04AD Thiocarbamide derivatives | |
| | | J04AK Other drugs for treatment of tuberculosis | |
| | | J04AM Combinations of drugs for treatment of tuberculosis | |
| | J04B DRUGS FOR TREATMENT OF LEPRA | | |
| | | J04BA Drugs for treatment of lepra | |
| J05 ANTIVIRALS FOR SYSTEMIC USE | | | |
| | J05A DIRECT ACTING ANTIVIRALS | | |
| | | J05AA Thiosemicarbazones | |
| | | J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors | |
| | | J05AC Cyclic amines | |
| | | J05AD Phosphonic acid derivatives | |
| | | J05AE Protease inhibitors | |
| | | J05AF Nucleoside and nucleotide reverse transcriptase inhibitors | |
| | | J05AG Non-nucleoside reverse transcriptase inhibitors | |
| | | J05AH Neuraminidase inhibitors | |
| | | J05AJ Integrase inhibitors | |
| | | J05AP Antivirals for treatment of HCV infections | |
| | | J05AR Antivirals for treatment of HIV infections, combinations | |
| | | J05AX Other antivirals | |
| J06 IMMUNE SERA AND IMMUNOGLOBULINS | | | |
| | J06A IMMUNE SERA | | |
| | | J06AA Immune sera | |
| | J06B IMMUNOGLOBULINS | | |
| | | J06BA Immunoglobulins, normal human | |
| | | J06BB Specific immunoglobulins | |
| | | J06BC Antibacterial monoclonal antibodies | |
| | | J06BD Antiviral monoclonal antibodies | |
| J07 VACCINES | | | |
| | J07A BACTERIAL VACCINES | | |
| | | J07AC Anthrax vaccines | |
| | | J07AD Brucellosis vaccines | |
| | | J07AE Cholera vaccines | |
| | | J07AF Diphtheria vaccines | |
| | | J07AG Haemophilus influenzae B vaccines | |
| | | J07AH Meningococcal vaccines | |
| | | J07AJ Pertussis vaccines | |
| | | J07AK Plague vaccines | |
| | | J07AL Pneumococcal vaccines | |
| | | J07AM Tetanus vaccines | |
| | | J07AN Tuberculosis vaccines | |
| | | J07AP Typhoid vaccines | |
| | | J07AR Typhus (exanthematicus) vaccines | |
| | | J07AX Other bacterial vaccines | |
| | J07B VIRAL VACCINES | | |
| | | J07BA Encephalitis vaccines | |
| | | J07BB Influenza vaccines | |
| | | J07BC Hepatitis vaccines | |
| | | J07BD Measles vaccines | |
| | | J07BE Mumps vaccines | |
| | | J07BF Poliomyelitis vaccines | |
| | | J07BG Rabies vaccines | |
| | | J07BH Rota virus diarrhea vaccines | |
| | | J07BJ Rubella vaccines | |
| | | J07BK Varicella zoster vaccines | |
| | | J07BL Yellow fever vaccines | |
| | | J07BM Papillomavirus vaccines | |
| | | J07BN Covid-19 vaccines | |
| | | J07BX Other viral vaccines | |
| | J07C BACTERIAL AND VIRAL VACCINES, COMBINED | | |
| | | J07CA Bacterial and viral vaccines, combined | |
| | J07X OTHER VACCINES | | |
| | | J07XA Parasitic vaccines | |
| | | | | |
| L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| | | | | |
| L01 ANTINEOPLASTIC AGENTS | | | |
| | L01A ALKYLATING AGENTS | | |
| | | L01AA Nitrogen mustard analogues | |
| | | L01AB Alkyl sulfonates | |
| | | L01AC Ethylene imines | |
| | | L01AD Nitrosoureas | |
| | | L01AG Epoxides | |
| | | L01AX Other alkylating agents | |
| | L01B ANTIMETABOLITES | | |
| | | L01BA Folic acid analogues | |
| | | L01BB Purine analogues | |
| | | L01BC Pyrimidine analogues | |
| | L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | | |
| | | L01CA Vinca alkaloids and analogues | |
| | | L01CB Podophyllotoxin derivatives | |
| | | L01CC Colchicine derivatives | |
| | | L01CD Taxanes | |
| | | L01CE Topoisomerase 1 (TOP1) inhibitors | |
| | | L01CX Other plant alkaloids and natural products | |
| | L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | | |
| | | L01DA Actinomycines | |
| | | L01DB Anthracyclines and related substances | |
| | | L01DC Other cytotoxic antibiotics | |
| | L01E PROTEIN KINASE INHIBITORS | | |
| | | L01EA BCR-ABL tyrosine kinase inhibitors | |
| | | L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors | |
| | | L01EC B-Raf serine-threonine kinase (BRAF) inhibitors | |
| | | L01ED Anaplastic lymphoma kinase (ALK) inhibitors | |
| | | L01EE Mitogen-activated protein kinase (MEK) inhibitors | |
| | | L01EF Cyclin-dependent kinase (CDK) inhibitors | |
| | | L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors | |
| | | L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors | |
| | | L01EJ Janus-associated kinase (JAK) inhibitors | |
| | | L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors | |
| | | L01EL Bruton's tyrosine kinase (BTK) inhibitors | |
| | | L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors | |
| | | L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors | |
| | | L01EX Other protein kinase inhibitors | |
| | L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | | |
| | | L01FA CD20 (Clusters of Differentiation 20) inhibitors | |
| | | L01FB CD22 (Clusters of Differentiation 22) inhibitors | |
| | | L01FC CD38 (Clusters of Differentiation 38) inhibitors | |
| | | L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors | |
| | | L01FE EGFR (Epidermal Growth Factor Receptor) inhibitors | |
| | | L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors | |
| | | L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors | |
| | | L01FX Other monoclonal antibodies and antibody drug conjugates | |
| | L01X OTHER ANTINEOPLASTIC AGENTS | | |
| | | L01XA Platinum compounds | |
| | | L01XB Methylhydrazines | |
| | | L01XD Sensitizers used in photodynamic/radiation therapy | |
| | | L01XF Retinoids for cancer treatment | |
| | | L01XG Proteasome inhibitors | |
| | | L01XH Histone deacetylase (HDAC) inhibitors | |
| | | L01XJ Hedgehog pathway inhibitors | |
| | | L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors | |
| | | L01XL Antineoplastic cell and gene therapy | |
| | | L01XX Other antineoplastic agents | |
| | | L01XY Combinations of antineoplastic agents | |
| L02 ENDOCRINE THERAPY | | | |
| | L02A HORMONES AND RELATED AGENTS | | |
| | | L02AA Estrogens | |
| | | L02AB Progestogens | |
| | | L02AE Gonadotropin releasing hormone analogues | |
| | | L02AX Other hormones | |
| | L02B HORMONE ANTAGONISTS AND RELATED AGENTS | | |
| | | L02BA Anti-estrogens | |
| | | L02BB Anti-androgens | |
| | | L02BG Aromatase inhibitors | |
| | | L02BX Other hormone antagonists and related agents | |
| L03 IMMUNOSTIMULANTS | | | |
| | L03A IMMUNOSTIMULANTS | | |
| | | L03AA Colony stimulating factors | |
| | | L03AB Interferons | |
| | | L03AC Interleukins | |
| | | L03AX Other immunostimulants | |
| L04 IMMUNOSUPPRESSANTS | | | |
| | L04A IMMUNOSUPPRESSANTS | | |
| | | L04AA Selective immunosuppressants | |
| | | L04AB Tumor necrosis factor alpha (TNF-α) inhibitors | |
| | | L04AC Interleukin inhibitors | |
| | | L04AD Calcineurin inhibitors | |
| | | L04AX Other immunosuppressants | |
| | | | | |
| M MUSCULO-SKELETAL SYSTEM |
| | | | | |
| M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | | | |
| | M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | | |
| | | M01AA Butylpyrazolidines | |
| | | M01AB Acetic acid derivatives and related substances | |
| | | M01AC Oxicams | |
| | | M01AE Propionic acid derivatives | |
| | | M01AG Fenamates | |
| | | M01AH Coxibs | |
| | | M01AX Other antiinflammatory and antirheumatic agents, non-steroids | |
| | M01B ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION | | |
| | | M01BA Antiinflammatory/antirheumatic agents in combination with corticosteroids | |
| | | M01BX Other antiinflammatory/antirheumatic agents in combination with other drugs | |
| | M01C SPECIFIC ANTIRHEUMATIC AGENTS | | |
| | | M01CA Quinolines | |
| | | M01CB Gold preparations | |
| | | M01CC Penicillamine and similar agents | |
| | | M01CX Other specific antirheumatic agents | |
| M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | | | |
| | M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | | |
| | | M02AA Antiinflammatory preparations, non-steroids for topical use | |
| | | M02AB Capsaicin and similar agents | |
| | | M02AC Preparations with salicylic acid derivatives | |
| | | M02AX Other topical products for joint and muscular pain | |
| M03 MUSCLE RELAXANTS | | | |
| | M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS | | |
| | | M03AA Curare alkaloids | |
| | | M03AB Choline derivatives | |
| | | M03AC Other quaternary ammonium compounds | |
| | | M03AX Other muscle relaxants, peripherally acting agents | |
| | M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS | | |
| | | M03BA Carbamic acid esters | |
| | | M03BB Oxazol, thiazine, and triazine derivatives | |
| | | M03BC Ethers, chemically close to antihistamines | |
| | | M03BX Other centrally acting agents | |
| | M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS | | |
| | | M03CA Dantrolene and derivatives | |
| M04 ANTIGOUT PREPARATIONS | | | |
| | M04A ANTIGOUT PREPARATIONS | | |
| | | M04AA Preparations inhibiting uric acid production | |
| | | M04AB Preparations increasing uric acid excretion | |
| | | M04AC Preparations with no effect on uric acid metabolism | |
| | | M04AX Other antigout preparations | |
| M05 DRUGS FOR TREATMENT OF BONE DISEASES | | | |
| | M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION | | |
| | | M05BA Bisphosphonates | |
| | | M05BB Bisphosphonates, combinations | |
| | | M05BC Bone morphogenetic proteins | |
| | | M05BX Other drugs affecting bone structure and mineralization | |
| M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM | | | |
| | M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM | | |
| | | M09AA Quinine and derivatives | |
| | | M09AB Enzymes | |
| | | M09AX Other drugs for disorders of the musculo-skeletal system | |
| | | | | |
| N NERVOUS SYSTEM |
| | | | | |
| N01 ANESTHETICS | | | |
| | N01A ANESTHETICS, GENERAL | | |
| | | N01AA Ethers | |
| | | N01AB Halogenated hydrocarbons | |
| | | N01AF Barbiturates, plain | |
| | | N01AG Barbiturates in combination with other drugs | |
| | | N01AH Opioid anesthetics | |
| | | N01AX Other general anesthetics | |
| | N01B ANESTHETICS, LOCAL | | |
| | | N01BA Esters of aminobenzoic acid | |
| | | N01BB Amides | |
| | | N01BC Esters of benzoic acid | |
| | | N01BX Other local anesthetics | |
| N02 ANALGESICS | | | |
| | N02A OPIOIDS | | |
| | | N02AA Natural opium alkaloids | |
| | | N02AB Phenylpiperidine derivatives | |
| | | N02AC Diphenylpropylamine derivatives | |
| | | N02AD Benzomorphan derivatives | |
| | | N02AE Oripavine derivatives | |
| | | N02AF Morphinan derivatives | |
| | | N02AG Opioids in combination with antispasmodics | |
| | | N02AJ Opioids in combination with non-opioid analgesics | |
| | | N02AX Other opioids | |
| | N02B OTHER ANALGESICS AND ANTIPYRETICS | | |
| | | N02BA Salicylic acid and derivatives | |
| | | N02BB Pyrazolones | |
| | | N02BE Anilides | |
| | | N02BF Gabapentinoids | |
| | | N02BG Other analgesics and antipyretics | |
| | N02C ANTIMIGRAINE PREPARATIONS | | |
| | | N02CA Ergot alkaloids | |
| | | N02CB Corticosteroid derivatives | |
| | | N02CC Selective serotonin (5HT1) agonists | |
| | | N02CD Calcitonin gene-related peptide (CGRP) antagonists | |
| | | N02CX Other antimigraine preparations | |
| N03 ANTIEPILEPTICS | | | |
| | N03A ANTIEPILEPTICS | | |
| | | N03AA Barbiturates and derivatives | |
| | | N03AB Hydantoin derivatives | |
| | | N03AC Oxazolidine derivatives | |
| | | N03AD Succinimide derivatives | |
| | | N03AE Benzodiazepine derivatives | |
| | | N03AF Carboxamide derivatives | |
| | | N03AG Fatty acid derivatives | |
| | | N03AX Other antiepileptics | |
| N04 ANTI-PARKINSON DRUGS | | | |
| | N04A ANTICHOLINERGIC AGENTS | | |
| | | N04AA Tertiary amines | |
| | | N04AB Ethers chemically close to antihistamines | |
| | | N04AC Ethers of tropine or tropine derivatives | |
| | N04B DOPAMINERGIC AGENTS | | |
| | | N04BA Dopa and dopa derivatives | |
| | | N04BB Adamantane derivatives | |
| | | N04BC Dopamine agonists | |
| | | N04BD Monoamine oxidase B inhibitors | |
| | | N04BX Other dopaminergic agents | |
| | N04C OTHER ANTIPARKINSON DRUGS | | |
| | | N04CX Other antiparkinson drugs | |
| N05 PSYCHOLEPTICS | | | |
| | N05A ANTIPSYCHOTICS | | |
| | | N05AA Phenothiazines with aliphatic side-chain | |
| | | N05AB Phenothiazines with piperazine structure | |
| | | N05AC Phenothiazines with piperidine structure | |
| | | N05AD Butyrophenone derivatives | |
| | | N05AE Indole derivatives | |
| | | N05AF Thioxanthene derivatives | |
| | | N05AG Diphenylbutylpiperidine derivatives | |
| | | N05AH Diazepines, oxazepines, thiazepines and oxepines | |
| | | N05AL Benzamides | |
| | | N05AN Lithium | |
| | | N05AX Other antipsychotics | |
| | N05B ANXIOLYTICS | | |
| | | N05BA Benzodiazepine derivatives | |
| | | N05BB Diphenylmethane derivatives | |
| | | N05BC Carbamates | |
| | | N05BD Dibenzo-bicyclo-octadiene derivatives | |
| | | N05BE Azaspirodecanedione derivatives | |
| | | N05BX Other anxiolytics | |
| | N05C HYPNOTICS AND SEDATIVES | | |
| | | N05CA Barbiturates, plain | |
| | | N05CB Barbiturates, combinations | |
| | | N05CC Aldehydes and derivatives | |
| | | N05CD Benzodiazepine derivatives | |
| | | N05CE Piperidinedione derivatives | |
| | | N05CF Benzodiazepine related drugs | |
| | | N05CH Melatonin receptor agonists | |
| | | N05CM Other hypnotics and sedatives | |
| | | N05CX Hypnotics and sedatives in combination, excl. barbiturates | |
| N06 PSYCHOANALEPTICS | | | |
| | N06A ANTIDEPRESSANTS | | |
| | | N06AA Non-selective monoamine reuptake inhibitors | |
| | | N06AB Selective serotonin reuptake inhibitors | |
| | | N06AF Monoamine oxidase inhibitors, non-selective | |
| | | N06AG Monoamine oxidase A inhibitors | |
| | | N06AX Other antidepressants | |
| | N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS | | |
| | | N06BA Centrally acting sympathomimetics | |
| | | N06BC Xanthine derivatives | |
| | | N06BX Other psychostimulants and nootropics | |
| | N06C PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION | | |
| | | N06CA Antidepressants in combination with psycholeptics | |
| | | N06CB Psychostimulants in combination with psycholeptics | |
| | N06D ANTI-DEMENTIA DRUGS | | |
| | | N06DA Anticholinesterases | |
| | | N06DX Other anti-dementia drugs | |
| N07 OTHER NERVOUS SYSTEM DRUGS | | | |
| | N07A PARASYMPATHOMIMETICS | | |
| | | N07AA Anticholinesterases | |
| | | N07AB Choline esters | |
| | | N07AX Other parasympathomimetics | |
| | N07B DRUGS USED IN ADDICTIVE DISORDERS | | |
| | | N07BA Drugs used in nicotine dependence | |
| | | N07BB Drugs used in alcohol dependence | |
| | | N07BC Drugs used in opioid dependence | |
| | N07C ANTIVERTIGO PREPARATIONS | | |
| | | N07CA Antivertigo preparations | |
| | N07X OTHER NERVOUS SYSTEM DRUGS | | |
| | | N07XA Gangliosides and ganglioside derivatives | |
| | | N07XX Other nervous system drugs | |
| | | | | |
| P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
| | | | | |
| P01 ANTIPROTOZOALS | | | |
| | P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES | | |
| | | P01AA Hydroxyquinoline derivatives | |
| | | P01AB Nitroimidazole derivatives | |
| | | P01AC Dichloroacetamide derivatives | |
| | | P01AR Arsenic compounds | |
| | | P01AX Other agents against amoebiasis and other protozoal diseases | |
| | P01B ANTIMALARIALS | | |
| | | P01BA Aminoquinolines | |
| | | P01BB Biguanides | |
| | | P01BC Methanolquinolines | |
| | | P01BD Diaminopyrimidines | |
| | | P01BE Artemisinin and derivatives, plain | |
| | | P01BF Artemisinin and derivatives, combinations | |
| | | P01BX Other antimalarials | |
| | P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS | | |
| | | P01CA Nitroimidazole derivatives | |
| | | P01CB Antimony compounds | |
| | | P01CC Nitrofuran derivatives | |
| | | P01CD Arsenic compounds | |
| | | P01CX Other agents against leishmaniasis and trypanosomiasis | |
| P02 ANTHELMINTICS | | | |
| | P02B ANTITREMATODALS | | |
| | | P02BA Quinoline derivatives and related substances | |
| | | P02BB Organophosphorous compounds | |
| | | P02BX Other antitrematodal agents | |
| | P02C ANTINEMATODAL AGENTS | | |
| | | P02CA Benzimidazole derivatives | |
| | | P02CB Piperazine and derivatives | |
| | | P02CC Tetrahydropyrimidine derivatives | |
| | | P02CE Imidazothiazole derivatives | |
| | | P02CF Avermectines | |
| | | P02CX Other antinematodals | |
| | P02D ANTICESTODALS | | |
| | | P02DA Salicylic acid derivatives | |
| | | P02DX Other anticestodals | |
| P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS | | | |
| | P03A ECTOPARASITICIDES, INCL. SCABICIDES | | |
| | | P03AA Sulfur containing products | |
| | | P03AB Chlorine containing products | |
| | | P03AC Pyrethrines, incl. synthetic compounds | |
| | | P03AX Other ectoparasiticides, incl. scabicides | |
| | P03B INSECTICIDES AND REPELLENTS | | |
| | | P03BA Pyrethrines | |
| | | P03BX Other insecticides and repellents | |
| | | | | |
| R RESPIRATORY SYSTEM |
| | | | | |
| R01 NASAL PREPARATIONS | | | |
| | R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | | |
| | | R01AA Sympathomimetics, plain | |
| | | R01AB Sympathomimetics, combinations excl. corticosteroids | |
| | | R01AC Antiallergic agents, excl. corticosteroids | |
| | | R01AD Corticosteroids | |
| | | R01AX Other nasal preparations | |
| | R01B NASAL DECONGESTANTS FOR SYSTEMIC USE | | |
| | | R01BA Sympathomimetics | |
| R02 THROAT PREPARATIONS | | | |
| | R02A THROAT PREPARATIONS | | |
| | | R02AA Antiseptics | |
| | | R02AB Antibiotics | |
| | | R02AD Anesthetics, local | |
| | | R02AX Other throat preparations | |
| R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | | | |
| | R03A ADRENERGICS, INHALANTS | | |
| | | R03AA Alpha- and beta-adrenoreceptor agonists | |
| | | R03AB Non-selective beta-adrenoreceptor agonists | |
| | | R03AC Selective beta-2-adrenoreceptor agonists | |
| | | R03AH Combinations of adrenergics | |
| | | R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics | |
| | | R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids | |
| | R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS | | |
| | | R03BA Glucocorticoids | |
| | | R03BB Anticholinergics | |
| | | R03BC Antiallergic agents, excl. corticosteroids | |
| | | R03BX Other drugs for obstructive airway diseases, inhalants | |
| | R03C ADRENERGICS FOR SYSTEMIC USE | | |
| | | R03CA Alpha- and beta-adrenoreceptor agonists | |
| | | R03CB Non-selective beta-adrenoreceptor agonists | |
| | | R03CC Selective beta-2-adrenoreceptor agonists | |
| | | R03CK Adrenergics and other drugs for obstructive airway diseases | |
| | R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | | |
| | | R03DA Xanthines | |
| | | R03DB Xanthines and adrenergics | |
| | | R03DC Leukotriene receptor antagonists | |
| | | R03DX Other systemic drugs for obstructive airway diseases | |
| R05 COUGH AND COLD PREPARATIONS | | | |
| | R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS | | |
| | | R05CA Expectorants | |
| | | R05CB Mucolytics | |
| | R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS | | |
| | | R05DA Opium alkaloids and derivatives | |
| | | R05DB Other cough suppressants | |
| | R05F COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS | | |
| | | R05FA Opium derivatives and expectorants | |
| | | R05FB Other cough suppressants and expectorants | |
| | R05X OTHER COLD PREPARATIONS | | |
| R06 ANTIHISTAMINES FOR SYSTEMIC USE | | | |
| | R06A ANTIHISTAMINES FOR SYSTEMIC USE | | |
| | | R06AA Aminoalkyl ethers | |
| | | R06AB Substituted alkylamines | |
| | | R06AC Substituted ethylene diamines | |
| | | R06AD Phenothiazine derivatives | |
| | | R06AE Piperazine derivatives | |
| | | R06AK Combinations of antihistamines | |
| | | R06AX Other antihistamines for systemic use | |
| R07 OTHER RESPIRATORY SYSTEM PRODUCTS | | | |
| | R07A OTHER RESPIRATORY SYSTEM PRODUCTS | | |
| | | R07AA Lung surfactants | |
| | | R07AB Respiratory stimulants | |
| | | R07AX Other respiratory system products | |
| | | | | |
| S SENSORY ORGANS |
| | | | | |
| S01 OPHTHALMOLOGICALS | | | |
| | S01A ANTIINFECTIVES | | |
| | | S01AA Antibiotics | |
| | | S01AB Sulfonamides | |
| | | S01AD Antivirals | |
| | | S01AE Fluoroquinolones | |
| | | S01AX Other antiinfectives | |
| | S01B ANTIINFLAMMATORY AGENTS | | |
| | | S01BA Corticosteroids, plain | |
| | | S01BB Corticosteroids and mydriatics in combination | |
| | | S01BC Antiinflammatory agents, non-steroids | |
| | S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION | | |
| | | S01CA Corticosteroids and antiinfectives in combination | |
| | | S01CB Corticosteroids/antiinfectives/mydriatics in combination | |
| | | S01CC Antiinflammatory agents, non-steroids and antiinfectives in combination | |
| | S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS | | |
| | | S01EA Sympathomimetics in glaucoma therapy | |
| | | S01EB Parasympathomimetics | |
| | | S01EC Carbonic anhydrase inhibitors | |
| | | S01ED Beta blocking agents | |
| | | S01EE Prostaglandin analogues | |
| | | S01EX Other antiglaucoma preparations | |
| | S01F MYDRIATICS AND CYCLOPLEGICS | | |
| | | S01FA Anticholinergics | |
| | | S01FB Sympathomimetics excl. antiglaucoma preparations | |
| | S01G DECONGESTANTS AND ANTIALLERGICS | | |
| | | S01GA Sympathomimetics used as decongestants | |
| | | S01GX Other antiallergics | |
| | S01H LOCAL ANESTHETICS | | |
| | | S01HA Local anesthetics | |
| | S01J DIAGNOSTIC AGENTS | | |
| | | S01JA Colouring agents | |
| | | S01JX Other ophthalmological diagnostic agents | |
| | S01K SURGICAL AIDS | | |
| | | S01KA Viscoelastic substances | |
| | | S01KX Other surgical aids | |
| | S01L OCULAR VASCULAR DISORDER AGENTS | | |
| | | S01LA Antineovascularisation agents | |
| | S01X OTHER OPHTHALMOLOGICALS | | |
| | | S01XA Other ophthalmologicals | |
| S02 OTOLOGICALS | | | |
| | S02A ANTIINFECTIVES | | |
| | | S02AA Antiinfectives | |
| | S02B CORTICOSTEROIDS | | |
| | | S02BA Corticosteroids | |
| | S02C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION | | |
| | | S02CA Corticosteroids and antiinfectives in combination | |
| | S02D OTHER OTOLOGICALS | | |
| | | S02DA Analgesics and anesthetics | |
| | | S02DC Indifferent preparations | |
| S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS | | | |
| | S03A ANTIINFECTIVES | | |
| | | S03AA Antiinfectives | |
| | S03B CORTICOSTEROIDS | | |
| | | S03BA Corticosteroids | |
| | S03C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION | | |
| | | S03CA Corticosteroids and antiinfectives in combination | |
| | S03D OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS | | |
| | | | | |
| V VARIOUS |
| | | | | |
| V01 ALLERGENS | | | |
| | V01A ALLERGENS | | |
| | | V01AA Allergen extracts | |
| V03 ALL OTHER THERAPEUTIC PRODUCTS | | | |
| | V03A ALL OTHER THERAPEUTIC PRODUCTS | | |
| | | V03AB Antidotes | |
| | | V03AC Iron chelating agents | |
| | | V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia | |
| | | V03AF Detoxifying agents for antineoplastic treatment | |
| | | V03AG Drugs for treatment of hypercalcemia | |
| | | V03AH Drugs for treatment of hypoglycemia | |
| | | V03AK Tissue adhesives | |
| | | V03AM Drugs for embolisation | |
| | | V03AN Medical gases | |
| | | V03AX Other therapeutic products | |
| | | V03AZ Nerve depressants | |
| V04 DIAGNOSTIC AGENTS | | | |
| | V04B URINE TESTS | | |
| | V04C OTHER DIAGNOSTIC AGENTS | | |
| | | V04CA Tests for diabetes | |
| | | V04CB Tests for fat absorption | |
| | | V04CC Tests for bile duct patency | |
| | | V04CD Tests for pituitary function | |
| | | V04CE Tests for liver functional capacity | |
| | | V04CF Tuberculosis diagnostics | |
| | | V04CG Tests for gastric secretion | |
| | | V04CH Tests for renal function and ureteral injuries | |
| | | V04CJ Tests for thyreoidea function | |
| | | V04CK Tests for pancreatic function | |
| | | V04CL Tests for allergic diseases | |
| | | V04CM Tests for fertility disturbances | |
| | | V04CX Other diagnostic agents | |
| V06 GENERAL NUTRIENTS | | | |
| | V06A DIET FORMULATIONS FOR TREATMENT OF OBESITY | | |
| | | V06AA Low-energy diets | |
| | V06B PROTEIN SUPPLEMENTS | | |
| | V06C INFANT FORMULAS | | |
| | | V06CA Nutrients without phenylalanine | |
| | V06D OTHER NUTRIENTS | | |
| | | V06DA Carbohydrates/proteins/minerals/vitamins, combinations | |
| | | V06DB Fat/carbohydrates/proteins/minerals/vitamins, combinations | |
| | | V06DC Carbohydrates | |
| | | V06DD Amino acids, incl. combinations with polypeptides | |
| | | V06DE Amino acids/carbohydrates/minerals/vitamins, combinations | |
| | | V06DF Milk substitutes | |
| | | V06DX Other combinations of nutrients | |
| V07 ALL OTHER NON-THERAPEUTIC PRODUCTS | | | |
| | V07A ALL OTHER NON-THERAPEUTIC PRODUCTS | | |
| | | V07AA Plasters | |
| | | V07AB Solvents and diluting agents, incl. irrigating solutions | |
| | | V07AC Blood transfusion, auxiliary products | |
| | | V07AD Blood tests, auxiliary products | |
| | | V07AN Incontinence equipment | |
| | | V07AR Sensitivity tests, discs and tablets | |
| | | V07AS Stomi equipment | |
| | | V07AT Cosmetics | |
| | | V07AV Technical disinfectants | |
| | | V07AX Washing agents etc. | |
| | | V07AY Other non-therapeutic auxiliary products | |
| | | V07AZ Chemicals and reagents for analysis | |
| V08 CONTRAST MEDIA | | | |
| | V08A X-RAY CONTRAST MEDIA, IODINATED | | |
| | | V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media | |
| | | V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media | |
| | | V08AC Watersoluble, hepatotropic X-ray contrast media | |
| | | V08AD Non-watersoluble X-ray contrast media | |
| | V08B X-RAY CONTRAST MEDIA, NON-IODINATED | | |
| | | V08BA Barium sulfate containing X-ray contrast media | |
| | V08C MAGNETIC RESONANCE IMAGING CONTRAST MEDIA | | |
| | | V08CA Paramagnetic contrast media | |
| | | V08CB Superparamagnetic contrast media | |
| | | V08CX Other magnetic resonance imaging contrast media | |
| | V08D ULTRASOUND CONTRAST MEDIA | | |
| | | V08DA Ultrasound contrast media | |
| V09 DIAGNOSTIC RADIOPHARMACEUTICALS | | | |
| | V09A CENTRAL NERVOUS SYSTEM | | |
| | | V09AA Technetium (99mTc) compounds | |
| | | V09AB Iodine (123I) compounds | |
| | | V09AX Other central nervous system diagnostic radiopharmaceuticals | |
| | V09B SKELETON | | |
| | | V09BA Technetium (99mTc) compounds | |
| | V09C RENAL SYSTEM | | |
| | | V09CA Technetium (99mTc) compounds | |
| | | V09CX Other renal system diagnostic radiopharmaceuticals | |
| | V09D HEPATIC AND RETICULO ENDOTHELIAL SYSTEM | | |
| | | V09DA Technetium (99mTc) compounds | |
| | | V09DB Technetium (99mTc), particles and colloids | |
| | | V09DX Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals | |
| | V09E RESPIRATORY SYSTEM | | |
| | | V09EA Technetium (99mTc), inhalants | |
| | | V09EB Technetium (99mTc), particles for injection | |
| | | V09EX Other respiratory system diagnostic radiopharmaceuticals | |
| | V09F THYROID | | |
| | | V09FX Various thyroid diagnostic radiopharmaceuticals | |
| | V09G CARDIOVASCULAR SYSTEM | | |
| | | V09GA Technetium (99mTc) compounds | |
| | | V09GB Iodine (125I) compounds | |
| | | V09GX Other cardiovascular system diagnostic radiopharmaceuticals | |
| | V09H INFLAMMATION AND INFECTION DETECTION | | |
| | | V09HA Technetium (99mTc) compounds | |
| | | V09HB Indium (111In) compounds | |
| | | V09HX Other diagnostic radiopharmaceuticals for inflammation and infection detection | |
| | V09I TUMOUR DETECTION | | |
| | | V09IA Technetium (99mTc) compounds | |
| | | V09IB Indium (111In) compounds | |
| | | V09IX Other diagnostic radiopharmaceuticals for tumour detection | |
| | V09X OTHER DIAGNOSTIC RADIOPHARMACEUTICALS | | |
| | | V09XA Iodine (131I) compounds | |
| | | V09XX Various diagnostic radiopharmaceuticals | |
| V10 THERAPEUTIC RADIOPHARMACEUTICALS | | | |
| | V10A ANTIINFLAMMATORY AGENTS | | |
| | | V10AA Yttrium (90Y) compounds | |
| | | V10AX Other antiinflammatory therapeutic radiopharmaceuticals | |
| | V10B PAIN PALLIATION (BONE SEEKING AGENTS) | | |
| | | V10BX Various pain palliation radiopharmaceuticals | |
| | V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS | | |
| | | V10XA Iodine (131I) compounds | |
| | | V10XX Various therapeutic radiopharmaceuticals | |
| V20 SURGICAL DRESSINGS | | | |